Proposed LCD DL40251: MolDX: Biomarker Testing for Risk Stratification in DCIS — WPS
Policy LCD-DL40251 · Oncology
New LCD on biomarker testing for DCIS may affect billing.
Code intelligence
0220U reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code 0220U.
Elevated code risk
Signal breakdown
1 shown · 1 total in platform
Risk: Elevated
0
Critical
0%
1
High
100%
0
Routine
0%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
Audit documentation
Building an audit file that includes 0220U?
The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Oncology audit pack — $349One-time purchase · not a subscription